IP Library Granted Patent US 9,290,794
Granted Patent B2
US 9,290,794 · App. 13/674,655 · Granted Mar 22, 2016

Mutant protease biosensors with enhanced detection characteristics

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,290,794
App. No.
13/674,655
Granted
Mar 22, 2016
Kind
B2
Abstract

A polynucleotide encoding a biosensor polypeptide comprising a modified circularly-permuted thermostable luciferase and a linker linking the C-terminal portion of the thermostable luciferase to the N-terminal portion of the thermostable luciferase. The modified circularly-permuted thermostable luciferase is modified relative to a parental circularly-permuted thermostable luciferase. The linker contains a sensor region capable of interacting with a target molecule in a cell. The modified circularly-permuted thermostable luciferase has an enhanced response after interaction of the biosensor with the target molecule relative to the parental circularly-permuted thermostable luciferase in the presence of the target molecule. Alternatively, the modified circularly-permuted thermostable luciferase has an enhanced response after interaction of the biosensor with the target molecule relative to the modified circularly-permuted thermostable luciferase in the absence of the target molecule.

Claims (5)

1. A polynucleotide encoding a circularly-permuted thermostable luciferase comprising a peptide linker linking the original N- and C-termini of the non-permuted thermostable luciferase, wherein the peptide linker comprises a granzyme B recognition site, wherein the circularly-permuted thermostable luciferase has increased luminescence following cleavage by granzyme B when compared to an uncleaved circularly-permuted thermostable luciferase, wherein the granzyme B recognition site is selected from the group consisting of GRIEADSE (SEQ ID NO:80), KSVGPDFG (SEQ ID NO:81), and GIETDSG (SEQ ID NO:82), and wherein the non-permuted thermostable luciferase has at least 90% identity to the amino acid sequence of SEQ ID NO:2 or at least 90% identity to the amino acid sequence of SEQ ID NO:4.

2. The polynucleotide of claim 1 , wherein the granzyme B recognition site is flanked by peptide linkers.

3. A vector comprising the polynucleotide of claim 1 .

4. A cell comprising the vector of claim 3 .

5. A kit comprising the polynucleotide of claim 1 .

Assignments (4)
SECURITY INTEREST Recorded Apr 3, 2019
From: PROMEGA CORPORATION; PROMEGA BIOSCIENCES, LLC; TERSO SOLUTIONS, INC.; ORION SEVEN, LLC; PROMEGA AVIATION LLC
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 048790/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2013
From: BINKOWSKI, BROCK; BUTLER, BRAEDEN; ENCELL, LANCE P.; FAN, FRANK; HOOK, BRAD; OTTO, PAUL; VIDUGIRIS, GEDIMINAS; WIGDAL, SUSAN; ZIMMERMAN, KRISTOPHER
To: PROMEGA CORPORATION
Reel/Frame 029654/0672 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2013
From: RISMA, KIMBERLY
To: CHILDREN'S HOSPITAL MEDICAL CENTER D/B/A CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER
Reel/Frame 029654/0761 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2013
From: CHILDREN'S HOSPITAL MEDICAL CENTER D/B/A CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER
To: PROMEGA CORPORATION
Reel/Frame 029654/0801 →